Certain medications cause acne breakouts because they interfere with your skin’s oil production, hormonal balance, or immune response in ways that clog pores and trigger inflammation. Corticosteroids, for instance, mimic cortisol and ramp up sebum output while enhancing inflammatory pathways — which is why someone placed on prednisone for an autoimmune flare might notice a sudden crop of uniform, dome-shaped pimples across their chest within days. Cancer drugs known as EGFR inhibitors are even more predictable offenders, producing acneiform rashes in 50 to 100 percent of patients who take them.
The list of acne-triggering medications extends well beyond steroids and cancer treatments. Lithium, certain hormonal contraceptives, anticonvulsants like phenytoin, the tuberculosis drug isoniazid, immunosuppressants such as cyclosporine, and even vitamin B12 all carry documented associations with breakouts. What makes drug-induced acne distinct from ordinary acne vulgaris is its appearance and behavior — it tends to show up suddenly as small, uniform pustules without the blackheads and whiteheads most people associate with breakouts. This article walks through the major medication categories known to cause acne, explains the biological mechanisms behind each one, identifies how drug-induced acne differs from the regular kind, and covers what you and your dermatologist can actually do about it.
Table of Contents
- What Biological Mechanisms Cause Medication-Induced Acne Breakouts?
- Corticosteroids and Steroid Acne — The Most Common Culprit
- EGFR Inhibitors and Cancer Treatment-Related Acne
- How to Tell Drug-Induced Acne Apart from Regular Acne
- Lithium, Hormonal Medications, and Less Obvious Triggers
- Anticonvulsants and Antituberculosis Drugs
- What Dermatologists Are Doing About Drug-Induced Acne
- Conclusion
- Frequently Asked Questions
What Biological Mechanisms Cause Medication-Induced Acne Breakouts?
Drug-induced acne is not a single phenomenon with a single cause. Different medications trigger breakouts through different pathways, which is part of why the resulting skin reactions can look so different from one drug to another. Corticosteroids, for example, increase sebum production directly while also enhancing toll-like receptor 2 (TLR2) expression in keratinocytes stimulated with Propionibacterium acnes — the bacterium most associated with inflammatory acne. On top of that, corticosteroids may promote yeast proliferation within hair follicles, creating a secondary mechanism for follicular eruptions. Oral and injectable forms carry a higher risk than inhaled or nasal formulations, which is an important distinction for patients managing conditions like asthma.
Hormonal medications work through a different route entirely. Testosterone, anabolic steroids like danazol and stanozolol, and older progestins with stronger androgenic properties all stimulate the sebaceous glands in much the same way endogenous androgens do during puberty. The result can be severe — testosterone and anabolic steroids are capable of triggering acne conglobata and acne fulminans, two of the most destructive forms of acne that can cause deep abscesses and scarring. By contrast, lithium accumulates at high concentrations in the skin and appears to induce neutrophil activity, though the exact mechanism behind lithium-related folliculitis remains incompletely understood even after decades of clinical observation. The takeaway is that “medication causes acne” is a broad statement covering at least four or five distinct biological pathways: increased sebum production, androgenic stimulation, immune modulation, inflammatory signaling, and direct follicular disruption. Knowing which pathway is at play matters because it influences how the breakout is treated.
Corticosteroids and Steroid Acne — The Most Common Culprit
Steroid acne is one of the most recognizable forms of drug-induced acne, and it has a characteristic presentation that sets it apart. Rather than the mixed comedones, papules, and cysts typical of acne vulgaris, steroid acne produces monomorphous dome-shaped papules — meaning the bumps all look the same size and shape. They tend to cluster on the chest and trunk rather than concentrating on the face, though facial involvement is certainly possible. Patients on systemic corticosteroids like prednisone, dexamethasone, or hydrocortisone are most at risk, particularly those on higher doses or longer courses. However, not everyone on corticosteroids will break out, and the severity can vary widely.
If you are prescribed a short burst of oral prednisone for poison ivy or an allergic reaction, your risk is lower than someone on months of immunosuppressive steroid therapy for lupus or organ transplant management. Inhaled corticosteroids for asthma and nasal sprays for allergies carry a meaningfully lower risk of triggering acne, so patients should not avoid those formulations out of skin concerns without discussing alternatives with their doctor. The acne typically resolves within weeks to months after the steroid is discontinued, but in some cases dermatologic treatment is needed to manage the breakout while the underlying condition still requires corticosteroid therapy. One important limitation: steroid acne can be difficult to distinguish from fungal folliculitis (pityrosporum folliculitis), since both can produce uniform papules on the trunk and both may be promoted by corticosteroid use. A dermatologist may need to perform a skin scraping or biopsy to tell them apart, because the treatments differ significantly — antifungals for one, antibiotics or retinoids for the other.
EGFR Inhibitors and Cancer Treatment-Related Acne
For cancer patients on EGFR inhibitors like cetuximab, erlotinib, or gefitinib, acneiform rash is not a rare side effect — it is a near-certainty. Up to 90 percent of patients on cetuximab develop cutaneous complications, with grade 3 to 4 adverse events occurring in 11 to 18 percent of cases. The rash typically appears within one week of starting treatment, which can be alarming for patients already dealing with the physical and emotional toll of a cancer diagnosis. What makes EGFR-inhibitor acne especially distinctive is where it shows up and what it lacks. Unlike regular acne, these eruptions often appear on the lower legs and the backs of the arms — areas where typical acne vulgaris almost never occurs.
The lesions also lack comedones, meaning there are no blackheads or whiteheads, just inflammatory papules and pustules. Men, patients with higher body weight, and those with naturally high sebaceous gland activity face the greatest risk of severe skin toxicity. There is a practical upside to the research here. A 2022 meta-analysis by Gorji and colleagues found that prophylactic oral tetracycline antibiotics reduce grade 2 or higher acneiform eruptions by 40 percent (relative risk of 0.6, 95 percent confidence interval 0.46 to 0.79, p less than 0.01). This means that for patients about to start EGFR inhibitor therapy, preemptive antibiotic treatment is a legitimate strategy worth discussing with their oncology team. The rash itself, ironically, has been correlated in some studies with better tumor response — so managing the skin side effects rather than stopping the drug is often the clinical priority.
How to Tell Drug-Induced Acne Apart from Regular Acne
Recognizing drug-induced acne matters because the treatment approach differs from standard acne care. The hallmark features to watch for are sudden onset, uniform appearance, and the absence of comedones. Regular acne vulgaris typically develops gradually over weeks or months and presents with a mix of lesion types — blackheads, whiteheads, papules, pustules, and sometimes cysts of varying sizes. Drug-induced acne, by contrast, tends to erupt quickly with lesions that all look strikingly similar to each other. Age is another differentiator. While acne vulgaris overwhelmingly affects adolescents and young adults, drug-induced acne can appear at any age regardless of skin type or acne history.
A 55-year-old who has never had a pimple in their life developing a sudden rash of uniform pustules after starting lithium for bipolar disorder is a textbook presentation. Location can also be a clue — drug-induced acne frequently favors the trunk, whereas hormonal acne vulgaris tends to concentrate along the jawline and lower face. The tradeoff in diagnosis is between speed and certainty. A dermatologist who takes a thorough medication history can often make a clinical diagnosis of drug-induced acne quickly, but confirming it requires either discontinuing the suspected medication and watching for improvement, or in ambiguous cases, performing a biopsy. Discontinuation is not always feasible — you cannot simply stop chemotherapy or lithium because of skin breakouts. In those situations, the focus shifts to managing the acne with topical or oral treatments while continuing the necessary medication, which requires coordination between the prescribing physician and a dermatologist.
Lithium, Hormonal Medications, and Less Obvious Triggers
Lithium occupies an unusual place among acne-causing medications because, unlike corticosteroids or androgens, it does not show a clear dose-dependent relationship with follicular eruptions. A patient on a low dose can break out just as severely as someone on a high dose, which makes it difficult to manage by simply adjusting the prescription. High concentrations of lithium accumulate locally in the skin, and the drug appears to induce neutrophil activity, but the precise mechanism remains incompletely understood. For patients with bipolar disorder who depend on lithium for mood stabilization, switching medications solely because of acne is a significant decision with real psychiatric consequences — this is not a tradeoff to take lightly. Hormonal medications present their own complexity. Not all oral contraceptives are equal when it comes to acne. Newer formulations with less androgenic progestins can actually improve acne, which is why some birth control pills are FDA-approved as acne treatments.
But older oral contraceptives containing progestins like medroxyprogesterone, implanted or intrauterine progesterone devices, and formulations that reduce circulating sex hormone binding globulin (SHBG) can aggravate acne by effectively increasing the androgenic activity reaching the skin. The warning here is specific: switching from one contraceptive to another is not always a lateral move for your skin. A pill that cleared up one person’s acne might worsen another’s, depending on the progestin component. Beyond the major categories, several other medications carry documented acne risk that patients and clinicians sometimes overlook. Cyclosporine, an immunosuppressant used after organ transplants, increases oil gland activity. Vitamin B12, often taken as a supplement without a second thought, is an established cause of acneiform eruptions. And halogen compounds — iodides and bromides — have what dermatologic literature describes as an “undoubted causal relationship” to acne, a phrasing that leaves little room for debate.
Anticonvulsants and Antituberculosis Drugs
Phenytoin, marketed as Dilantin and used for epilepsy, has acne listed as a well-documented common side effect. This is worth knowing because epilepsy patients are often on phenytoin for years or even decades, and chronic low-grade acne that never quite resolves may be attributed to other causes when the medication is actually the driver. If you have been on phenytoin and are dealing with persistent breakouts that do not respond to typical acne treatments, raising the medication as a possible factor with your neurologist is a reasonable step.
Isoniazid, a cornerstone of tuberculosis treatment worldwide, causes acne in approximately 1.4 to 2.5 percent of patients based on two large clinical studies. That percentage may sound small, but isoniazid is prescribed to millions of people globally, and the acne typically develops after prolonged use — meaning patients may not connect their skin changes to a medication they started months earlier. Because tuberculosis treatment regimens are long and strict, discontinuing isoniazid over acne is rarely appropriate, but awareness allows for concurrent dermatologic management.
What Dermatologists Are Doing About Drug-Induced Acne
The clinical approach to drug-induced acne has become more nuanced in recent years, particularly in oncology. The finding that prophylactic antibiotics can reduce EGFR-inhibitor rashes by 40 percent represents a shift toward prevention rather than reaction. Oncologists and dermatologists are increasingly collaborating before patients even begin certain chemotherapy regimens, developing skin management plans in advance rather than scrambling after a rash appears.
For non-oncology drug-induced acne, the standard approach remains identifying and, when possible, substituting the offending medication. When substitution is not an option — as with lithium for bipolar disorder or cyclosporine after a transplant — topical retinoids, benzoyl peroxide, and oral antibiotics can manage symptoms effectively. The broader recognition that drug-induced acne is mechanistically distinct from acne vulgaris is slowly changing how dermatologists tailor treatment, moving away from one-size-fits-all acne protocols toward targeted interventions based on the specific drug and pathway involved.
Conclusion
Medications cause acne through several distinct biological pathways — increased sebum production from corticosteroids, androgenic stimulation from hormones and anabolic steroids, immune disruption from lithium and EGFR inhibitors, and direct follicular effects from drugs like phenytoin and isoniazid. Recognizing the pattern — sudden onset, uniform lesions, absence of comedones, unusual body locations — is the first step toward getting the right diagnosis and the right treatment rather than struggling with standard acne therapies that may not address the actual cause. If you suspect a medication is behind your breakouts, the most productive step is to bring a detailed medication list — including supplements like B12 — to your dermatologist and discuss the timeline of when your skin changes began relative to starting or adjusting any prescriptions.
Do not stop prescribed medications on your own. Drug-induced acne is manageable, often reversible after discontinuation, and in many cases treatable even while the causative medication continues. The key is getting the right people — your prescribing physician and a dermatologist — talking to each other about your skin.
Frequently Asked Questions
How quickly does drug-induced acne appear after starting a medication?
It varies by drug. EGFR inhibitor rashes typically appear within one week. Steroid acne can develop within days to weeks of starting systemic corticosteroids. Isoniazid-related acne usually appears only after prolonged use over months. The timeline is one of the clues that helps distinguish drug-induced acne from other causes.
Will my acne go away if I stop taking the medication causing it?
In most cases, drug-induced acne resolves within weeks to months after discontinuing the causative medication. However, stopping a prescribed medication should always be a decision made with your doctor — never unilaterally — since the condition being treated may be far more serious than the acne.
Can over-the-counter acne products treat drug-induced acne?
They can help manage symptoms in mild cases, particularly benzoyl peroxide and salicylic acid. However, drug-induced acne often responds differently than regular acne vulgaris because the underlying mechanism is different. Prescription options like topical retinoids or oral antibiotics may be more effective, especially for moderate to severe eruptions.
Does the dose of medication affect how bad the acne gets?
It depends on the drug. Corticosteroids and androgens tend to cause worse acne at higher doses. Lithium, notably, does not show a clear dose-dependent relationship — lower doses can cause breakouts just as readily as higher ones. EGFR inhibitors cause rash in the majority of patients regardless of dose, though severity may vary.
Is drug-induced acne the same as an allergic reaction to medication?
No. Drug-induced acne results from the medication’s pharmacologic effects on the skin — how the drug works in the body — not from an immune-mediated allergic reaction. An allergic drug rash typically involves hives, itching, and swelling, while drug-induced acne produces acne-like papules and pustules through mechanisms like increased oil production or follicular disruption.
